SCHEMBL14845011

SCHEMBL14845011

CC1(C)CCC=C(C(=O)CCCCCO)C1

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 1/20 0.33
▸ CYP4A11 Q02928 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.32
▸ FFAR1 O14842 1/20 0.32
▸ FFAR4 Q5NUL3 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ S1PR1 P21453 1/20 0.31
▸ S1PR3 Q99500 1/20 0.31
▸ HSD17B3 P37058 5/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11369860 0.81 MEN1 (0.36) ALDH1A1MAPT
SCHEMBL17976889 0.78 FAAH (0.39) MAPT
SCHEMBL11374411 0.73 ALDH1A1 (0.31) ALDH1A1
SCHEMBL11973867 0.66 NPC1 (0.31) ALDH1A1
SCHEMBL6574616 0.62 HDAC3 (0.37) FFAR4ALDH1A1MAPTSMN1; SMN2S1PR1
SCHEMBL22639456 0.61 GPR84 (0.36) GPR84FFAR1FFAR4KDM4EMAPT
SCHEMBL898668 0.56 — —
SCHEMBL2525609 0.55 PAOX (0.59) GPR84FFAR1FFAR4KDM4EALDH1A1
SCHEMBL10865193 0.55 PAOX (0.59) GPR84FFAR1FFAR4KDM4EALDH1A1
SCHEMBL4793246 0.55 PAOX (0.59) GPR84FFAR1FFAR4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2747886-B1 SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES FIRMENICH & CIE (CH) 2018-11-14 — — EP disclosed
EP-2970067-B1 SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES FIRMENICH & CIE (CH) 2017-08-16 — — EP disclosed
US-9714263-B2 Selective hydrogenation of aldehydes with Ru/bidentate ligands complexes FIRMENICH SA (CH) 2017-07-25 — — US disclosed
US-20160039853-A1 SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES FIRMENICH SA (CH) 2016-02-11 — — US disclosed
EP-2970067-A1 SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES Firmenich SA (CH) 2016-01-20 — — EP disclosed
US-9090534-B2 Selective hydrogenation of aldehyde with ru/bidentate ligands complexes FIREMENICH SA (CH) 2015-07-28 — — US disclosed
US-9090534-B2 Selective hydrogenation of aldehyde with ru/bidentate ligands complexes FIREMENICH SA (CH) 2015-07-28 — — US disclosed
US-9090534-B2 Selective hydrogenation of aldehyde with ru/bidentate ligands complexes FIREMENICH SA (CH) 2015-07-28 — — US disclosed
WO-2014139854-A1 SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES FIRMENICH SA (CH) 2014-09-18 — — WO disclosed
US-20140243526-A1 SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES FIRMENICH SA (CH) 2014-08-28 — — US disclosed
US-20140243526-A1 SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES FIRMENICH SA (CH) 2014-08-28 — — US disclosed
US-20140243526-A1 SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES FIRMENICH SA (CH) 2014-08-28 — — US disclosed
EP-2747886-A1 SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES Firmenich SA (CH) 2014-07-02 — — EP disclosed
WO-2013050297-A1 SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES FIRMENICH SA (CH) 2013-04-11 — — WO disclosed
WO-2013050297-A1 SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES FIRMENICH SA (CH) 2013-04-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039853-A1 SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES ADH5, ADH1A, ADH1C CYP4F2 387/4885CYP4A11 1852/4885GPR84 2679/4885
US-20140243526-A1 SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES ADH5, ADH1A, HAO2 CYP4F2 276/4885CYP4A11 2389/4885GPR84 3199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback